Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0003542
UniProt IDP42765
Primary gene name(s)ACAA2
Synonym gene name(s)unknown
Protein name3-ketoacyl-CoA thiolase, mitochondrial
Protein functionAbolishes BNIP3-mediated apoptosis and mitochondrial damage. {ECO:0000269|PubMed:18371312}.
Subcellular locationMitochondrion {ECO:0000269|PubMed:18371312}. Note=Colocalizes with BNIP3 in the mitochondria.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: P42765
Gene Ontology
(Biological Process)
Complete annatation
cellular response to hypoxia [GO:0071456];
cholesterol biosynthetic process [GO:0006695];
fatty acid beta-oxidation [GO:0006635];
negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109];
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]
Gene Ontology
(Molecular Function)
Complete annatation
acetyl-CoA C-acyltransferase activity [GO:0003988];
poly(A RNA binding [GO:0044822]
Gene Ontology
(Cellular Component)
Complete annatation
extracellular exosome [GO:0070062];
mitochondrial inner membrane [GO:0005743];
mitochondrion [GO:0005739]
Protein-protein interaction115713
Phylogenetic treeP42765
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
      unknown
Brass et al., Science, 2008
      unknown
Smith et al., J. Immunol, 2010
      unknown
Interferon-stimulated
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model


DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD3-0.3458645065351680.3438020737346830.464567406789415
AZA vs. DISU-0.1708778857047070.5010002778799840.935014607725149
AZA vs. IL70.369407745688670.05510090651942520.684338622413067
AZA vs. SAHA-0.1781752646175980.4653655206382860.802622409393768
DISU vs. CD30.1638721168291980.6979401318479670.788472334201205
DISU vs. IL70.5306822210859210.03680232855550080.25126589808613
DISU vs. SAHA-0.005483691079388820.9850273116627290.997928641020292
DMSO vs. AZA-0.01400352553066030.9334668180650811
DMSO vs. CD30.3227607708983880.3894495097854250.504172627388282
DMSO vs. DISU0.1555397525494830.5254311320219780.916529650671672
DMSO vs. IL70.3903821063812360.03022972452138950.352239847277554
DMSO vs. SAHA-0.1706859303764570.4692257716522030.795198651138014
HIV vs. Mock in Activation-0.10020161116360.9046643191739910.999983755607037
HIV vs. Mock in Latency-0.04221708248095470.8480200459612230.999834320637052
IL7 vs. CD30.7222746205790740.04822566142641070.106521892538143
SAHA vs. CD30.144029668544750.698781377387040.779469678550903
SAHA vs. IL7-0.5496694080149890.02447415565842490.114465846228699
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) unknown
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.19707 0.163119
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
1.061 1.175 1.418 1.556 1.284
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
unknown unknown unknown unknown

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

PDB Accession Method Resolution Chain Structure Preview
4C2J X-ray 2.0Å A/B/C/D=1-397.
4C2K X-ray 2.0Å A/B/C/D=1-397.

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Vpr enhances 23842279

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
hsa00062 Fatty acid elongation - Homo sapiens (human)
hsa00071 Fatty acid degradation - Homo sapiens (human)
hsa00280 Valine# leucine and isoleucine degradation - Homo sapiens (human)
hsa01100 Metabolic pathways - Homo sapiens (human)
hsa01212 Fatty acid metabolism - Homo sapiens (human)
Menu